食品伙伴網(wǎng)訊    據(jù)歐盟食品安全局（EFSA）消息，應(yīng)歐盟委員會(huì)的要求，歐盟食品安全局就人工合成的反式白藜蘆醇（trans-resveratrol）作為新型食品的安全性發(fā)布意見。

    申請(qǐng)人擬將這種新型食品作為食品補(bǔ)充劑用于膠囊或片劑，每日用量為150毫克/天。歐盟專家組經(jīng)過評(píng)估認(rèn)為，代謝物反式白藜蘆醇硫酸鹽可以阻礙人體CYP酶，并且可能與CYP2C9代謝后的藥物起反應(yīng)。最后認(rèn)為，按照規(guī)定條件使用反式白藜蘆醇是安全的。

    部分原文報(bào)道如下：

    Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% （w/w）。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

    原文鏈接：<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>